RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

Abstract

ALN-RSV01 was safe and may have beneficial effects on long-term allograft function in LTX patients infected with RSV. Clinical trial registered with www.clinicaltrials.gov (NCT 00658086).